Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension

被引:489
作者
Mereles, Derliz
Ehlken, Nicola
Kreuscher, Sandra
Ghofrani, Stefanie
Hoeper, Marius M.
Halank, Michael
Meyer, F. Joachim
Karger, Gabriele
Buss, Jan
Juenger, Jana
Holzapfel, Nicole
Opitz, Christian
Winkler, Joerg
Herth, Felix F. J.
Wilkens, Heinrike
Katus, Hugo A.
Olschewski, Horst
Gruenig, Ekkehard
机构
[1] Heidelberg Univ, Dept Cardiol Pneumol, Heidelberg, Germany
[2] Heidelberg Univ, Dept Psychosomat Med, Heidelberg, Germany
[3] Heidelberg Univ, Thoraxklin, Dept Internal Med Pneumol & Crit Care Med, Heidelberg, Germany
[4] Clin Rehabil, Heidelberg, Germany
[5] Univ Hosp 1, Dept Internal Med, Dresden, Germany
[6] Univ Giessen, Dept Pneumol, Giessen, Germany
[7] Leibniz Univ Hannover, Dept Pneumol, Hannover, Germany
[8] Univ Leipzig, Dept Pneumol, D-7010 Leipzig, Germany
[9] Univ Homburg, Dept Pneumol, D-6650 Homburg, Germany
[10] DRK Hosp Westend, Dept Cardiol, Berlin, Germany
[11] Med Univ Graz, Div Pulm, Graz, Austria
关键词
rehabilitation; exercise; hypertension; pulmonary; pulmonary heart disease; quality of life;
D O I
10.1161/CIRCULATIONAHA.106.618397
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Pulmonary hypertension (PH) is associated with restricted physical capacity, limited quality of life, and a poor prognosis because of right heart failure. The present study is the first prospective randomized study to evaluate the effects of exercise and respiratory training in patients with severe symptomatic PH. Methods and Results-Thirty patients with PH (21 women; mean age, 50 +/- 13 years; mean pulmonary artery pressure, 50 +/- 15 mm Hg; mean World Health Organization [WHO] class, 2.9 +/- 0.5; pulmonary arterial hypertension, n=23; chronic thromboembolic PH, n=7) on stable disease-targeted medication were randomly assigned to a control (n=15) and a primary training (n=15) group. Medication remained unchanged during the study period. Primary end points were the changes from baseline to week 15 in the distance walked in 6 minutes and in scores of the Short Form Health Survey quality-of-life questionnaire. Changes in WHO functional class, Borg scale, and parameters of echocardiography and gas exchange also were assessed. At week 15, patients in the primary and secondary training groups had an improved 6-minute walking distance; the mean difference between the control and the primary training group was 111 m (95% confidence interval, 65 to 139 m; P < 0.001). Exercise training was well tolerated and improved scores of quality of life, WHO functional class, peak oxygen consumption, oxygen consumption at the anaerobic threshold, and achieved workload. Systolic pulmonary artery pressure values at rest did not change significantly after 15 weeks of exercise and respiratory training ( from 61 +/- 18 to 54 +/- 18 mm Hg) within the training group. Conclusions-This study indicates that respiratory and physical training could be a promising adjunct to medical treatment in severe PH. The effects add to the beneficial results of modern medical treatment.
引用
收藏
页码:1482 / 1489
页数:8
相关论文
共 37 条
[1]   Medical therapy for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines [J].
Badesch, DB ;
Abman, SH ;
Ahearn, GS ;
Barst, RJ ;
McCrory, DC ;
Simonneau, G ;
McLaughlin, VV .
CHEST, 2004, 126 (01) :35S-62S
[2]   Diagnosis and differential assessment of pulmonary arterial hypertension [J].
Barst, RJ ;
McGoon, M ;
Torbicki, A ;
Sitbon, O ;
Krowka, MJ ;
Olschewski, H ;
Gaine, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :40S-47S
[3]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[4]   Exercise training intervention after coronary angioplasty: The ETICA trial [J].
Belardinelli, R ;
Paolini, I ;
Cianci, G ;
Piva, R ;
Georgiou, D ;
Purcaro, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) :1891-1900
[5]   PSYCHOPHYSICAL BASES OF PERCEIVED EXERTION [J].
BORG, GAV .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1982, 14 (05) :377-381
[6]   CONTROLLED TRIAL OF PHYSICAL-TRAINING IN CHRONIC HEART-FAILURE - EXERCISE PERFORMANCE, HEMODYNAMICS, VENTILATION, AND AUTONOMIC FUNCTION [J].
COATS, AJS ;
ADAMOPOULOS, S ;
RADAELLI, A ;
MCCANCE, A ;
MEYER, TE ;
BERNARDI, L ;
SOLDA, PL ;
DAVEY, P ;
ORMEROD, O ;
FORFAR, C ;
CONWAY, J ;
SLEIGHT, P .
CIRCULATION, 1992, 85 (06) :2119-2131
[7]   Combined endurance/resistance training reduces plasma TNF-α receptor levels in patients with chronic heart failure and coronary artery disease [J].
Conraads, VM ;
Beckers, P ;
Bosmans, J ;
De Clerck, LS ;
Stevens, WJ ;
Vrints, CJ ;
Brutsaert, DL .
EUROPEAN HEART JOURNAL, 2002, 23 (23) :1854-1860
[8]   ALTERATIONS OF SKELETAL-MUSCLE IN CHRONIC HEART-FAILURE [J].
DREXLER, H ;
RIEDE, U ;
MUNZEL, T ;
KONIG, H ;
FUNKE, E ;
JUST, H .
CIRCULATION, 1992, 85 (05) :1751-1759
[9]   Primary pulmonary hypertension [J].
Gaine, SP ;
Rubin, LJ .
LANCET, 1998, 352 (9129) :719-725
[10]   Sildenafil citrate therapy for pulmonary arterial hypertension [J].
Galiè, N ;
Ghofrani, HA ;
Torbicki, A ;
Barst, RJ ;
Rubin, LJ ;
Badesch, D ;
Fleming, T ;
Parpia, T ;
Burgess, G ;
Branzi, A ;
Grimminger, F ;
Kurzyna, M ;
Simonneau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2148-2157